BMRA Biomerica: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

biomerica.com - graphic logo of issuer BMRA

Biomerica, Inc. (BMRA) faces threats to profitability due to FDA bureaucracy and pressure from more affordable technologies, although business efficiency has stabilized through the automation of production costs. This chart on GURU.Markets reflects the asset's valuation in terms of EV/EBITDA at 0.00, which complements the strategy to promote non-invasive home cancer tests via pharmacy retail to simplify the early detection of pathologies.

Biomerica, Inc - BMRA Total Company Value to Operating Income Before Depreciation Ratio (period 11/23/2025 - 11/14/2026)

Biomerica (BMRA) - metric breakdowns and financial figures

- stock price and consensus target price:
Stock Quotes Biomerica Inc.|BMRA - Average Forecast Price
- company stock capitalization data:
Market Value Biomerica, Inc|BMRA - Company Buyout Price
- book value of equity indicators:
Book Value per Share Biomerica|BMRA - Book Valuation of Business|Market Value to Book Value Ratio biomerica.com|BMRA - Company Total Asset Base
- company liabilities and liquidity data:
Total Debt to Capital Biomerica, Inc.|BMRA - Long-Term Debt to Equity|Short-Term Debt to Capital Biomerica Inc|BMRA - Company Total Debt Obligations|Debt to Book Capitalization Ratio Biomerica Inc|BMRA - Long-Term Debt|Company Short-Term Debt Biomerica|Quick Ratio biomerica.com
- financial results and valuation multiples details:
BMRA - Company Net Income|Expected Profit Biomerica, Inc.|BMRA - Company Value to Net Income|Forward P/E Multiple Biomerica Inc.|BMRA - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Biomerica Inc.|BMRA - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Biomerica|BMRA - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months biomerica.com|BMRA - Earnings per share increase in current year|Earnings growth forecast for next year Biomerica, Inc.
- sales volume and revenue indicators:
BMRA - Company Gross Revenue|Company Projected Revenue Biomerica|BMRA - Market Cap to Revenue Ratio|Forward P/S Multiple Biomerica Inc.
Comprehensive company analysis:BMRA (Biomerica Inc.)
Product sample of biomerica.com

For Biomerica, Inc., whose value is based on years of physician trust in the accuracy of diagnostic tests, this indicator determines the real value of the business relative to its ability to generate cash flow. The ratio of total enterprise value to operating profit, illustrated through the EV/EBITDA multiple trend, excludes the impact of taxes and debt load. The dynamics of this curve allow an investor to distinguish temporary stagnation from fundamental asset consolidation.

Competitor analysis

Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization agilent.com A|Total Company Value to Operating Income Before Depreciation Ratio Quest Diagnostics (DGX)|ILMN - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio Exact Sciences Corporation EXAS|RVTY: EV/EBITDA Multiple|BIO - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization anbio.com|soterahealth.com (SHC) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization quidel.com (QDEL)|OPK: Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple CDNA (CareDx Corp)|EV/EBITDA Multiple Maravai MRVI|FLGT - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LAB (Standard BioTools Inc.) - Enterprise Value to Operating Income Before Depreciation|CTKB: EV/EBITDA Multiple|OSUR - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Exagen|Company Value to EBITDA MDxHealth Inc. MDXH|Enterprise Value to EBITDA Ratio LUCD (Lucid Diagnostics Inc.)|Total Company Value to Operating Income Before Depreciation Ratio Prenetics|Insight Molecular Diagnostics Inc - Enterprise Value to EBITDA Ratio|trinitybiotech.com (TRIB) - Company Value to EBITDA|prophaselabs.com - EV/EBITDA Multiple|AIMD (Ainos Corp) - Enterprise Value to Operating Income Before Depreciation|Co-Diagnostics Inc (CODX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|HSCS - Total Company Value to Operating Income Before Depreciation Ratio|CDIO (Cardio Diagnostics Holdings, Inc.) - EV/EBITDA Multiple|ONCO: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple VRAX|EV/EBITDA Multiple Bluejay (BJDX)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization aspirawh.com AWH|AXDX: Enterprise Value to Operating Income Before Depreciation|CNTG: Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio Enzo Biochem ENZ|Fresh2 Group (FRES) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA GTG Labs (GENE)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization 23andMe Holding Co|Enterprise Value to EBITDA Ratio Psychemedics (PMD)